The Nitty Gritty on GLP-1 Agonists & Their Role in Weight-Neutral Diabetes Care
Megan Muñoz, RN, MSN, CMSRN, CDCES
How Do I Support Clients’ Use of GLP-1 Agonists, When They’re Often Promoted for Weight-Loss Qualities?
- GLP-1 Options & T2D Pathophysiology
- GLP-1 Impacts
- Changing The Paradigm in Diabetes Care From Focusing on Weight Loss to Uniting On The Glucose Lowering Effect of GLP-1
- Reframing The Weight-Focused Use of GLP-1s